Overview
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
Status:
Completed
Completed
Trial end date:
2014-10-01
2014-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study will compare how well PF-06473871 works versus placebo in reducing skin scarring after scar revision surgery of existing breast scars. The study will also evaluate the safety of PF-06473871 in healthy adult subjects.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Pfizer
Criteria
Inclusion Criteria:- Subjects must have hypertrophic (raised) breast scars from previous surgery
- Subjects must be healthy
Exclusion Criteria:
- Currently pregnant or pregnant during the 6 months, prior to inclusion in the study or
breast-feeding.
- Presence of history of breast cancer